Market Overview:
The global breast tissue markers market generated revenue worth US$ 2.7 billion in 2022. The market is predicted to reach a value of US$ 6.5 billion by 2033-end, advancing at 8.4% CAGR over the decade. The Breast Tissue Markers Market is a critical component of breast healthcare, specializing in the precise localization and diagnosis of breast abnormalities, notably in breast cancer cases. These markers are essential tools employed during various diagnostic procedures, including mammography, ultrasound, and MRI-guided breast biopsies, facilitating the accurate identification of suspicious lesions. Furthermore, they play a vital role in guiding minimally invasive procedures and surgical interventions, aiding in the removal of malignant tissue while preserving healthy breast tissue. As breast cancer awareness and early detection efforts continue to gain prominence, the market experiences growth driven by technological advancements and a commitment to improving diagnostic accuracy and patient outcomes.
Cancer is the second-leading cause of death globally, with its increased incidence in both developed and developing countries. Breast cancer is the most commonly diagnosed type and it affects the morphology of human breasts. Identifying tumor markers is crucial for clinical management, diagnostics, staging, therapeutic response evaluation, and treatment development.
Well-established molecular markers like hormone receptors, HER-2 oncogene, Ki-67, and p53 proteins, as well as genes for hereditary breast cancer, are essential for the development of effective and targeted therapies.
- Metal breast tissue markers accounted for a market share of 73% in 2022.
- Revenue from breast tissue markers accounted for 17.5% share of the global oncology biomarkers market in 2022.
Market Growth Factors:
- Escalating Breast Cancer Cases: The market is significantly influenced by the growing incidence of breast cancer on a global scale. As breast cancer continues to rank among the foremost causes of cancer-related fatalities in women, there has been an upsurge in demand for precise lesion localization and accurate diagnosis.
- Progress in Diagnostic Technology: The evolution of medical imaging technologies, encompassing mammography, ultrasound, and MRI, has spurred the creation of more sophisticated and precise diagnostic procedures. Breast tissue markers are an indispensable component of these procedures, further propelling the markets expansion.
- Surge in Minimally Invasive Techniques: The trend favoring minimally invasive breast biopsy procedures, guided by cutting-edge imaging methods, has been a key driver for the adoption of breast tissue markers. These markers facilitate precise localization of lesions, alleviating patient discomfort and enhancing diagnostic precision.
- Customized Medical Approaches: The paradigm shift towards personalized medicine and targeted therapies in breast cancer treatment necessitates pinpoint tissue localization for exacting interventions. Breast tissue markers play an instrumental role in guiding these therapies, augmenting their efficacy.
- Heightened Awareness and Early Detection: The mounting consciousness regarding breast health and the significance of early detection through regular screenings has spurred greater demand for breast tissue markers. Early diagnosis remains pivotal in enhancing breast cancer prognosis.
- Innovative Marker Innovations: Continuous research and development endeavors incessantly improve breast tissue marker technologies. Innovations in marker design and materials enhance their efficacy and user-friendliness, further propelling market growth.
- Supportive Regulatory Framework: Regulatory authorities are increasingly highlighting the importance of precise breast cancer diagnosis, fostering an environment conducive to the adoption of breast tissue markers.
- Regional Disparities: Market dynamics exhibit variance across regions due to disparities in breast cancer prevalence, healthcare infrastructure, and awareness levels. Emerging markets offer growth potential as healthcare accessibility advances.
- Competitive Market Landscape: The presence of numerous prominent players specializing in breast tissue markers intensifies competition and fosters innovation within the market, culminating in the development of cutting-edge marker solutions.
You Can Customize this Report As per Your Requirement Click Here@ https://www.persistencemarketresearch.com/request-customization/29812
Country-wise Insights:
What Makes the United States a Lucrative Market for Companies Selling Breast Tissue Markers?
“High Mortality Rates Associated with Invasive Breast Cancer”
The United States accounted for 31.9% share of the global breast tissue markers market in 2022.
Breast cancer diagnostics have increased in the United States due to the high frequency of breast cancer. This has attracted several players to actively participate in this market.
- According to Breastcancer.org statistics for 2022, in the United States, breast cancer accounts for nearly 30% of the new cancer cases in females. About 1 in every 8 females is expected to develop invasive breast cancer in their lifetime. As of Jan 2022, more than 3.8 million females were suffering from breast cancer in the United States.
There has been tremendous growth in the adoption of diagnostic and screening practices in the United States.
- As per the National Breast Cancer Coalition 2022, between 1980 and 2000, there was a 400% increase in the diagnosis of ductal carcinoma in situ (DCIS) among women aged 20 to 49, while those over 50 years experienced a 900% increase in diagnosis rate. The number of females suffering from metastatic breast cancer is foreseen to increase from 140,230 in 2018 to 169,347 by the end of 2025.
Market Segmentation: Key Segments of Breast Tissue Markers Industry Research
Product:
- Metal
- Titanium Breast Tissue Markers
- Stainless Steel Breast Tissue Markers
- Nickel Breast Tissue Markers
- Non-metal
- Ceramic Breast Tissue Markers
- Zirconium Oxide Breast Tissue Markers
Shape:
- Coil
- Ribbon
- Butterfly
- V-Shape
- Others
Material:
- Biodegradable
- Non-biodegradable
End User:
- Hospitals
- Ambulatory Surgical Centers
- Cancer Research Centers
- Diagnostic Centers
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Our Report: E-Cigarette Market-https://www.globenewswire.com/en/news-release/2023/11/28/2786681/0/en/E-Cigarette-Industry-Booms-as-China-Leads-Global-Market-Expected-to-Hit-US-8-Billion-by-2030-Recent-Report-by-Persistence-Market-Research.html
About Persistence Market Research:
Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges.
Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.
Contact
Persistence Market Research
Teerth Technospace, Unit B-704
Survey Number – 103, Baner
Mumbai Bangalore Highway
Pune 411045 India
Email: [email protected]
Web: https://www.persistencemarketresearch.com
COMTEX_444145394/2840/2023-11-28T15:23:43
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Sahyadri Times journalist was involved in the writing and production of this article.
